Truist Financial
VRCA icon

Truist Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

Truist Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,055
Closed -$15.3K – 2635
2024
Q3 		$15.3K Hold
1,055
– – ﹤0.01% 2479
2024
Q2 		$76.9K Hold
1,055
– – ﹤0.01% 2594
2024
Q1 		$62.4K Hold
1,055
– – ﹤0.01% 2574
2023
Q4 		$77.2K Sell
1,055
-538
-34% -$22.1K ﹤0.01% 2583
2023
Q3 		$61.9K Hold
1,593
– – ﹤0.01% 2545
2023
Q2 		$91.9K Buy
1,593
+463
+41% +$28.1K ﹤0.01% 2520
2023
Q1 		$73.4K Hold
1,130
– – ﹤0.01% 2523
2022
Q4 		$31.1K Hold
1,130
– – ﹤0.01% 2529
2022
Q3 		$33K Hold
1,130
– – ﹤0.01% 2481
2022
Q2 		$21K Hold
1,130
– – ﹤0.01% 2603
2022
Q1 		$92K Buy
+1,130
New +$93.1K ﹤0.01% 2617

Other funds holding VRCA

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return